SOUTH SAN FRANCISCO, Calif., March 25, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced financial results for the fourth quarter and fiscal year ended December 31, 2007.
